“Centros de Excelencia Internacionales en Farmacia Hospitalaria”; una nueva iniciativa de la SEFH; el papel del farmacéutico clínico en la optimización de los antimicrobianos en Irlanda del Norte
Resumen
Palabras clave
Texto completo:
PDF (English)Referencias
Scott MG, Scullin C, Hogg A, Fleming GF, McElnay JC. Integrated medicines management to medicines optimisation in Northern Ireland (2000–2014): a review. Eur J Hosp Pharm 2015;0:1–7.
Scullin C, Scott M, Hogg A, McElnay J. An innovative approach to integrated medicines management. J Eval Clin Pract 2007; 13: 781-788.
Davies S. Annual Report of the Chief Medical Officer 2011: Volume Two. Infections and the Rise of Antimicrobial Resistance. (Last accessed: 21 February 2016). Disponible en: http://www.dh.gov.uk/health/2013/03/cmo-vol2
UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. (Last accessed: 21 February 2016). Disponible en: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf
Doron S and David LE. Antimicrobial stewardship. Mayo Clin Proc 2011; 86(11):1113-23.
Public Health England. Antimicrobial Stewardship: Start Smart the Focus. 2015. (Last accessed: 22 February 2016). Disponible en: www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-the-focus
Aldeyab MA, McElnay JC, Scott MG, Lattyak WJ, Darwish Elhajji et al. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking. J Antimicrob Chemother 2014; 69(4):1132-41.
Aldeyab MA, Kearney MP, Scott MG, Aldiab MA, Alahmadi YM et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012; 67(12):2988-96.
Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Funston C, Savage K,Kelly D, Aldiab MA, McElnay JC. Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother 2009; 53(5):2082-8.
Aldeyab MA, Monnet DL, López-Lozano JM, Hughes CM, Scott MG et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008; 62(3):593-600.
DOI: http://dx.doi.org/10.7399%2Ffh.2016.40.4.10535
Enlaces refback
- No hay ningún enlace refback.
Farmacia Hospitalaria
Sociedad Española de Farmacia Hospitalaria. C/ Serrano n. 40 2º Dcha. - 28001 Madrid
eISSN: 2171-8695
ISSN-L: 1130-6343
Dep. Legal: M-39835-2012
Correo electrónico de contacto: [email protected]
Los artículos publicados en esta revista se distribuyen con la licencia: Creative Commons Attribution 4.0.
La revista Farmacia Hospitalaria no cobra tasas por el envío de trabajos, ni tampoco cuotas por la publicación de sus artículos.